This study is assessing the safety and immunogenicity of ferritin nanoparticles expressing native-like HIV-1 envelope trimers followed by an mRNA boost in adults without HIV between the ages of 18 to 55 . This study is currently enrolling participants.
About Viola Appiah Danquah
This author has not written his bio yet.
But we are proud to say that Viola Appiah Danquah contributed 2 entries already.
Entries by Viola Appiah Danquah
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit